Showing results (191-200 of 626) with videos related to

Sort By:
Pageof 63
BMC Cancer|April 21, 2010
Epidemiological evaluation of concordance between initial diagnosis and central pathology review in a comprehensive and prospective series of sarcoma patients in the Rhone-Alpes regionAntoine Lurkin, Francoise Ducimetière, Dominique Ranchère Vince, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 25, 2014
Gynecologic Cancer InterGroup (GCIG) consensus review for carcinoid tumors of the ovaryNicholas Simon Reed, Eva Gomez-Garcia, Dolores Gallardo-Rincon, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 18, 2014
Gynecologic Cancer InterGroup (GCIG) consensus review for endometrial stromal sarcomaFrédéric Amant, Anne Floquet, Michael Friedlander, et al.
Clinical Sarcoma Research|September 7, 2012
Recombinant erythropoietin for the anaemia of patients with advanced Gastrointestinal Stromal Tumours (GIST) receiving imatinib: an active agent only in non progressive patientsFlorence Duffaud, Caroline Even, Isabelle Ray-Coquard, et al.
European Journal of Cancer (Oxford, England : 1990)|October 1, 2021
Population-adjusted indirect treatment comparison of the SOLO1 and PAOLA-1/ENGOT-ov25 trials evaluating maintenance olaparib or bevacizumab or the combination of both in newly diagnosed, advanced BRCA-mutated ovarian cancerIgnace Vergote, Isabelle Ray-Coquard, Daniel M Anderson, et al.
Bulletin Du Cancer|January 31, 2008
[Imatinib and solid tumours]Samia Arifi, Hiba El Sayadi, Armelle Dufresne, et al.
Cancer|September 10, 2008
A phase 2 trial of whole-brain radiotherapy combined with intravenous chemotherapy in patients with brain metastases from breast cancerPhilippe A Cassier, Isabelle Ray-Coquard, Marie-Pierre Sunyach, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|January 29, 2025
Mucinous ovarian carcinoma: Impact of ovarian stimulation, hormonal contraception, and hormone replacement therapyChloé Barbier de Reulle, Marine Rebotier, Nicolas Chopin, et al.
Histopathology|June 3, 2015
DICER1 and FOXL2 mutations in ovarian sex cord-stromal tumours: a GINECO Group studyThibault Goulvent, Isabelle Ray-Coquard, Stéphane Borel, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 31, 2022
Long-term outcomes after definitive radiotherapy with modern techniques for unresectable soft tissue sarcomaBenoît Allignet, Waisse Waissi, Xavier Geets, et al.
Pageof 63